BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced it will begin testing for monkeypox using the U.S. Centers for Disease Control and ...
Developed in collaboration with Amazon Web Services, Test Finder is now available on Labcorp.com "Clinicians are under increasing pressure to do more with less," said Dr. Brian Caveney, Labcorp's ...
Innovative GFAP blood biomarker test expands Labcorp's (LH) portfolio of tests for diseases including Alzheimer's disease, multiple sclerosis, glioblastoma and brain injuries BURLINGTON, N.C., April ...
This electron microscopic (EM) image depicted a monkeypox virion, obtained from a clinical sample associated with the 2003 prairie dog outbreak. It was a thin section image from of a human skin sample ...
Labcorp will begin testing for monkeypox by using the CDC’s orthopoxvirus test and is the first national laboratory to offer this PCR test. The testing will be done at Labcorp’s largest laboratory in ...
DEERFIELD, Ill. & BURLINGTON, N.C.--(BUSINESS WIRE)--Walgreens and LabCorp® (NYSE: LH) today announced a collaboration through which LabCorp will develop and operate patient service centers within ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Labcorp will begin testing for monkeypox using the CDC's ...
Illumina, Inc. (NASDAQ: ILMN) and Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced an expanded collaboration to advance precision oncology ...
Labcorp’s testing capabilities are getting a little broader with the $237.5 million acquisition of certain laboratory assets from BioReference Health, a subsidiary of Opko Health. The BioReference ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results